P

Protagonist Therapeutics
D

PTGX

64.816
USD
-0.20
(-0.31%)
مغلق
حجم التداول
13,414
الربح لكل سهم
-2
العائد الربحي
-
P/E
89
حجم السوق
4,032,288,787
أصول ذات صلة الأخبار المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.